全球醫藥物流市場 - 2023-2030
市場調查報告書
商品編碼
1382549

全球醫藥物流市場 - 2023-2030

Global Pharmaceutical Logistics Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 187 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

醫藥物流涉及製造、加工、運輸材料和資源。它甚至涉及與向客戶處理製成品相關的活動。對於任何一家製藥公司來說,物流公司在其運作中發揮著非常關鍵的作用。原因是他們有責任按時交付設備和藥品,因為有時會出現危急和緊急情況,患者迫切需要它們。在這種情況下,每一秒都很重要。

藥品物流是任何製藥企業營運中最重要的階段之一,因為這些活動具有高度的時間敏感度。在正確的時間、地點和劑量為正確的患者提供正確的藥物非常重要,最重要的是以正確的價格。

市場動態:促進因素與限制因素

冷鏈物流進步不斷

冷鏈物流的進步是預測期間推動市場發展的重要因素之一。冷鏈物流確保藥品在特定溫度範圍內儲存和運輸,以保持其功效和安全性。溫度監控和控制技術的進步有助於防止溫度偏差,並降低產品變質的風險。

例如,2021 年 2 月,領先的供應鏈視覺性供應商 Sensitech 擴展了其物聯網設備套件,涵蓋了航空公司批准的非鋰電池型號,用於在貨物通過飛機運輸時即時追蹤貨物。

TempTale GEO 和 VizComm View 產品的增強系列支援包括疫苗、藥品和測試套件在內的運輸,並提供經過驗證的資料,從而能夠做出關鍵的接受/拒絕決策,無論貨物如何移動- 空中、陸地或海上。 Sensitech 是 Carrier Global Corporation 的一部分,Carrier Global Corporation 是全球領先的健康、安全和永續建築和冷鏈解決方案提供商。

此外,醫藥產業的成長、醫藥產業逆向物流需求的增加以及國際貿易活動的增加等因素預計將在預測期內推動全球醫藥物流市場的成長。此外,對溫度敏感的藥品需求的成長以及用於藥品物流的RFID技術預計很快就會為藥品物流行業創造機會。

市場動態:克制

藥品物流和儲存缺乏標準化是預測期內阻礙市場成長的因素之一。藥品物流和倉儲需求受到多種因素的影響,但缺乏標準和認證對市場帶來了挑戰。這導致人們對倉庫空間品質和靈活性的擔憂,並增加了製造商適應行業要求的壓力。

在溫度合規性或容納自動化設備方面升級設施並不簡單。在技​​術和產品處理方面培訓和培養員工需要大量的財務支出。因此,醫藥物流標準化的缺乏預計將限制醫藥物流市場的成長。

目錄

第 1 章:方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章:定義與概述

第 3 章:執行摘要

  • 按服務類型分類的片段
  • 按運輸方式分割的片段
  • 按藥品類型分類的片段
  • 按地區分類的片段

第 4 章:市場動態

  • 影響因素
    • 促進要素
      • 科技進步的崛起
      • 製藥業逆向物流需求增加
    • 限制
      • 藥品物流倉儲缺乏標準化
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 管道分析
  • 未滿足的需求
  • DMI 意見

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章:按服務類型

  • 冷鏈物流
  • 非冷鏈物流

第 8 章:依運輸方式

  • 空氣

第 9 章:依藥品類型

  • 醫藥化學品
  • 生物製藥
  • 醫藥最終產品
  • 其他

第 10 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章:公司簡介

  • AIT Worldwide Logistics, Inc
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Yusen Logistics
  • Air Canada Cargo
  • CEVA Logistics SA
  • Continental Carriers Pvt Ltd
  • Deutsche Post AG
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • AWL
  • Nippon Express Holdings

第 13 章:附錄

簡介目錄
Product Code: PH1646

Overview

Pharmaceutical logistics deals with manufacturing, processing, shipping materials, and resources. It even deals with activities related to the handling of manufactured goods to their customers. For any Pharmaceutical company, the logistics companies play a very crucial role in its functioning. The reason is that they have the responsibility to deliver equipment and drugs on time as at times there are critical and emergencies where the patient needs it urgently. In such a situation every second counts.

Pharmaceutical logistics is one of the most important stages of the operations for any pharmaceutical business as the activities are highly time-sensitive. It is very critical to provide the right medicine to the right patient at the right time, place and dosage and most importantly at the right price.

Market Dynamics: Drivers and Restraints

Rise in advancements in cold chain logistics

Advancements in cold chain logistics are one of the significant factors that help the market to drive during the forecast period. Cold chain logistics ensures that pharmaceutical products are stored and transported at specific temperature ranges to maintain their efficacy and safety. Advancements in temperature monitoring and control technology help prevent temperature excursions, reducing the risk of product spoilage.

For instance, in February 2021, leading supply chain visibility provider Sensitech expanded its suite of IoT devices to include air-carrier-approved and non-lithium battery models for real-time tracking of shipments when cargo is traveling by plane.

The enhanced family of TempTale GEO and VizComm View products support shipments including vaccines, pharmaceuticals and test kits with validated data, enabling critical accept/reject decision-making, regardless of how cargo is moving - by air, land or sea. Sensitech is a part of Carrier Global Corporation, the leading global provider of healthy, safe and sustainable building and cold chain solutions.

Furthermore, factors such as growth in the pharmaceutical sector, increase in demand for reverse logistics in the pharmaceutical sector and increase in international trade activities are anticipated to boost the growth of the global pharmaceutical logistics market during the forecast period. Moreover, the rise in demand for temperature-sensitive pharmaceutical drugs, and RFID technologies for pharmaceutical logistics is expected to create an opportunity for the pharmaceutical logistics industry shortly.

Market Dynamics: Restraint

Lack of standardization in pharmaceutical logistics and storage is one of the factors that hamper the market growth during the forecast period. Pharmaceutical logistics and storage demand is influenced by various sources, but the absence of standards and accreditations poses challenges to the market. This leads to concerns about warehouse space quality and flexibility, and increased pressure on manufacturers to adapt to industry requirements.

It is not straightforward to upgrade the facility in terms of temperature compliance or accommodating automated equipment. Training and growing employees in technology and product handling require significant financial expenditure. As a result, the lack of standardization in pharmaceutical logistics is expected to restrict pharmaceutical logistics market growth.

Segment Analysis

The global pharmaceutical logistics market is segmented based on service type, mode of transport, pharmaceutical product type and region.

The cold chain logistics segment from the service type segment accounted for approximately 41.7% Pharmaceutical Logistics market share

The cold chain logistics segment from the service type segment accounted for approximately 41.7% and it is expected to be dominated during the forecast period. Cold chain logistics is the technology and process that allows for the safe transport of temperature-sensitive goods and products along the supply chain. It relies heavily on science to evaluate and accommodate the link between temperature and perishability. Any product is known to be labelled "perishable" will likely need cold chain management.

For instance, in March 2022, Lineage Logistics LLC, the world's largest and most innovative temperature-controlled industrial REIT and logistics solutions, acquired MTC Logistics, a leading cold-chain provider in four strategic locations on or near the ports of Baltimore, MD, Wilmington, DE, and Mobile, AL. These facilities will expand Lineage's current footprint, which already includes over 400 strategically positioned facilities with a combined capacity of over 2 billion cubic feet across 19 nations.

Moreover, in December 2020, A.P. Moller - Maersk has signed a three-year logistics agreement with Novo Nordisk, covering ocean services and inland logistics. The agreement aims to reduce the pharmaceutical company's carbon footprint in transportation by using sustainable biofuel to power selected Maersk vessels. The agreement demonstrates A.P. Moller-Maersk's rapid transformation into a modern end-to-end logistics company. The partnership also aligns with Novo Nordisk's ambitious sustainability goals, as it demonstrates the company's commitment to sustainability.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the increasing sales of generic drugs, as well as reforms in the healthcare sector favoring generics, several regional and international companies, collaborations with the key players and others help this region to have the highest market share during the forecast period.

For instance, in April 2023, MD Logistics, LLC, a group company of Japan-based Nippon Express Holdings, has opened Garner 2000 Pharmaceutical Logistics Centre, a dedicated pharmaceutical warehouse established in Garner, North Carolina in January this year.

North Carolina is a key hub for the pharmaceutical industry in the United States (US), with numerous major pharmaceutical manufacturers and life science companies having expanded into the state. It is also home to many research institutes and universities that have amassed significant medical knowledge and technologies.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the pharmaceutical logistics market where the COVID-19 pandemic has necessitated the need for temperature-sensitive storage facilities for vaccinations. Also, there was an high demand for temperature-sensitive proteins and nutritional supplements due to evolving consumer lifestyles and dietary habits.

Market Segmentation

Service Type

  • Cold Chain Logistics
  • Non-Cold Chain Logistics

Mode of Transport

  • Air
  • Water
  • Road
  • Rail

Pharmaceutical Product Type

  • Pharmaceutical Chemicals
  • Bio-Pharmaceuticals
  • Pharmaceutical end products
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

major global players in the market include: AIT Worldwide Logistics, Inc., Yusen Logistics, Air Canada Cargo, CEVA Logistics SA, Continental Carriers Pvt Ltd, Deutsche Post AG, FedEx Corporation, Kerry Logistics Network Limited, AWL, Nippon Express Holdings and among others.

Key Developments

  • In November 2022, UPS acquired healthcare logistics provider Bomi Group to expand its temperature-controlled facilities. With this acquisition, the UPS Healthcare network in Europe and Latin America will gain access to temperature-controlled facilities in 14 countries and over 3,000 highly qualified Bomi Group team members.
  • In November 2020, Pharma Logistics and ConsortiEX, market leaders in serving the needs of pharmacies and hospitals, launched their new program which is focused on improving inventory efficiency strategic collaboration programs, reducing cost, improving patient safety, and managing cash flow and compliance for their customers.

Why Purchase the Report?

  • To visualize the global pharmaceutical logistics market segmentation based on service type, mode of transport, pharmaceutical product type and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of pharmaceutical logistics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global pharmaceutical logistics market report would provide approximately 61 tables, 58 figures and 187 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Service Type
  • 3.2. Snippet by Mode of Transport
  • 3.3. Snippet by Pharmaceutical Product Type
  • 3.4. Snippet by Region

4. Market Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the technological advancements
      • 4.1.1.2. Increase in demand for reverse logistics in the pharmaceutical sector
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of standardization in pharmaceutical logistics and storage
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pipeline Analysis
  • 5.6. Unmet Needs
  • 5.7. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Service Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 7.1.2. Market Attractiveness Index, By Service Type
  • 7.2. Cold Chain Logistics *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-Cold Chain Logistics

8. By Mode of Transport

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 8.1.2. Market Attractiveness Index, By Mode of Transport
  • 8.2. Air*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Water
  • 8.4. Road
  • 8.5. Rail

9. By Pharmaceutical Product Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 9.1.2. Market Attractiveness Index, By Pharmaceutical Product Type
  • 9.2. Pharmaceutical Chemicals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bio-Pharmaceuticals
  • 9.4. Pharmaceutical end products
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.5.1. China
      • 10.5.5.2. India
      • 10.5.5.3. Japan
      • 10.5.5.4. Australia
      • 10.5.5.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. AIT Worldwide Logistics, Inc *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Yusen Logistics
  • 12.3. Air Canada Cargo
  • 12.4. CEVA Logistics SA
  • 12.5. Continental Carriers Pvt Ltd
  • 12.6. Deutsche Post AG
  • 12.7. FedEx Corporation
  • 12.8. Kerry Logistics Network Limited
  • 12.9. AWL
  • 12.10. Nippon Express Holdings

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us